Personality and the use of cancer screenings - Results of the German National Cohort.

Cancer screening Health screening Mammography Personality Prostate cancer

Journal

Preventive medicine reports
ISSN: 2211-3355
Titre abrégé: Prev Med Rep
Pays: United States
ID NLM: 101643766

Informations de publication

Date de publication:
May 2024
Historique:
received: 08 12 2023
revised: 04 03 2024
accepted: 05 03 2024
medline: 27 3 2024
pubmed: 27 3 2024
entrez: 27 3 2024
Statut: epublish

Résumé

To determine the association between personality characteristics and use of different cancer screenings. We used data from the German National Cohort (NAKO; mean age was 53.0 years (SD: 9.2 years)) - a population-based cohort study. A total of 132,298 individuals were included in the analyses. As outcome measures, we used (self-reported): stool examination for blood (haemoccult test, early detection of bowel cancer), colonoscopy (screening for colorectal cancer), skin examination for moles (early detection of skin cancer), breast palpation by a doctor (early detection of breast cancer), x-ray examination of the breast ("mammography", early detection of breast cancer), cervical smear test, finger examination of the rectum (early detection of prostate cancer), and blood test for prostate cancer (determination of Prostate-Specific Antigen level). The established Big Five Inventory-SOEP was used to quantify personality factors. It was adjusted for several covariates based on the Andersen model. Unadjusted and adjusted multiple logistic regressions were computed. A higher probability of having a skin examination for moles, for example, was associated with a higher conscientiousness (OR: 1.07, p < 0.001), higher extraversion (OR: 1.03, p < 0.001), higher agreeableness (OR: 1.02, p < 0.001), lower openness to experience (OR: 0.98, p < 0.001) and higher neuroticism (OR: 1.07, p < 0.001) among the total sample. Depending on the outcome used, the associations slightly varied. Particularly higher levels of extraversion, neuroticism and conscientiousness are associated with the use of different cancer screenings. Such knowledge may help to better understand non-participation in cancer screening examinations from a psychological perspective.

Identifiants

pubmed: 38533391
doi: 10.1016/j.pmedr.2024.102677
pii: S2211-3355(24)00092-5
pmc: PMC10963220
doi:

Types de publication

Journal Article

Langues

eng

Pagination

102677

Informations de copyright

© 2024 The Author(s).

Déclaration de conflit d'intérêts

The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Auteurs

André Hajek (A)

Department of Health Economics and Health Services Research, University Medical Center Hamburg-Eppendorf, Hamburg Center for Health Economics, Hamburg, Germany.

Heiko Becher (H)

Heidelberg University Hospital, Heidelberg Institute of Global Health, Heidelberg, Germany.

Hermann Brenner (H)

Division of Clinical Epidemiology and Aging Research, German Cancer Research Center (DKFZ), Heidelberg, Germany.

Bernd Holleczek (B)

Division of Clinical Epidemiology and Aging Research, German Cancer Research Center (DKFZ), Heidelberg, Germany.
Saarland Cancer Registry, Saarbrücken, Germany.

Verena Katzke (V)

Department of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany.

Rudolf Kaaks (R)

Department of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany.

Heike Minnerup (H)

Institute for Epidemiology and Social Medicine, Faculty of Medicine, University of Münster, Münster, Germany.

André Karch (A)

Institute for Epidemiology and Social Medicine, Faculty of Medicine, University of Münster, Münster, Germany.

Hansjörg Baurecht (H)

Department of Epidemiology and Preventive Medicine, University of Regensburg, 93053 Regensburg, Germany.

Michael Leitzmann (M)

Department of Epidemiology and Preventive Medicine, University of Regensburg, 93053 Regensburg, Germany.

Annette Peters (A)

Institute of Epidemiology, Helmholtz Zentrum München - German Research Center for Environmental Health (GmbH), Neuherberg, Germany.
Chair of Epidemiology, Institute for Medical Information Processing, Biometry and Epidemiology, Medical Faculty, Ludwig-Maximilians-Universität München, Munich, Germany.

Sylvia Gastell (S)

German Institute of Human Nutrition Potsdam-Rehbruecke, Nuthetal, Germany.

Wolfgang Ahrens (W)

Leibniz Institute for Prevention Research and Epidemiology - BIPS, Bremen, Germany.

Ulrike Haug (U)

Leibniz Institute for Prevention Research and Epidemiology - BIPS, Bremen, Germany.

Katharina Nimptsch (K)

Molecular Epidemiology Research Group, Max Delbrück Center for Molecular Medicine in the Helmholtz Association (MDC), Berlin, Germany.

Tobias Pischon (T)

Molecular Epidemiology Research Group, Max Delbrück Center for Molecular Medicine in the Helmholtz Association (MDC), Berlin, Germany.
Max Delbrueck Center for Molecular Medicine in the Helmholtz Association (MDC), Biobank Technology Platform, Berlin, Germany.
Charité - Universitaetsmedizin Berlin, Corporate Member of Freie Universitaet Berlin, Humboldt-Universitaet zu Berlin, Berlin, Germany.

Karin B Michels (KB)

Institute for Prevention and Cancer Epidemiology, Faculty of Medicine and Medical Center, University of Freiburg, Freiburg, Germany.

Anja Dorrn (A)

Institute for Prevention and Cancer Epidemiology, Faculty of Medicine and Medical Center, University of Freiburg, Freiburg, Germany.

Carolina J Klett-Tammen (CJ)

Department for Epidemiology, Helmholtz Centre for Infection Research, Brunswick, Germany.

Stefanie Castell (S)

Department for Epidemiology, Helmholtz Centre for Infection Research, Brunswick, Germany.

Stefan N Willich (SN)

Institute of Social Medicine, Epidemiology and Health Economics, Charité - Universitätsmedizin Berlin, Berlin, Germany.

Thomas Keil (T)

Institute of Social Medicine, Epidemiology and Health Economics, Charité - Universitätsmedizin Berlin, Berlin, Germany.
Institute of Clinical Epidemiology and Biometry, University of Würzburg, Würzburg, Germany.
State Institute of Health I, Bavarian Health and Food Safety Authority, Erlangen, Germany.

Sabine Schipf (S)

Institute for Community Medicine, Department SHIP/Clinical-Epidemiological Research, University Medicine Greifswald, Greifswald, Germany.

Claudia Meinke-Franze (C)

Institute for Community Medicine, Department SHIP/Clinical-Epidemiological Research, University Medicine Greifswald, Greifswald, Germany.

Volker Harth (V)

Institute for Occupational and Maritime Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.

Nadia Obi (N)

Institute for Occupational and Maritime Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.

Hans-Helmut König (HH)

Department of Health Economics and Health Services Research, University Medical Center Hamburg-Eppendorf, Hamburg Center for Health Economics, Hamburg, Germany.

Classifications MeSH